TrialBMC musculoskeletal disorders2023

Topical use of tranexamic acid can reduce opioid consumption compared with intravenous use for patients undergoing primary total hip arthroplasty: a prospective randomized controlled trial.

Lei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.